Search

Your search keyword '"Guo, Matthew"' showing total 230 results

Search Constraints

Start Over You searched for: Author "Guo, Matthew" Remove constraint Author: "Guo, Matthew"
230 results on '"Guo, Matthew"'

Search Results

1. Reimagining Undergraduate Medical Education in a Post-COVID-19 Landscape

6. Remote Hub Lab – RHL: Broadly Accessible Technologies for Education and Telehealth

16. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

19. Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

23. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

24. Racial and Ethnic Disparities in Outcomes Among Newborns with Congenital Diaphragmatic Hernia

26. Cell-Free DNA (cfDNA)-Based Measurable Residual Disease (MRD) Detection As a Predictor of Relapse Post-Allogeneic Blood or Marrow Transplant (alloBMT) in Patients with Myeloid Malignancies

28. Adagrasib: a novel inhibitor for KRASG12C-mutated non-small-cell lung cancer.

29. A phase 2, multicenter, parallel-group, open-label study of vudalimab (XmAb20717), a PD-1 x CTLA-4 bispecific antibody, alone or in combination with chemotherapy or targeted therapy in patients with molecularly defined subtypes of metastatic castration-resistant prostate cancer.

30. Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis

31. Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

32. Author response: Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis

36. Clinical and Ultrasonic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors

37. Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors

38. Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis

39. Reimagining Undergraduate Medical Education in a Post-COVID-19 Landscape.

45. Prostitutes, prostitution and STD/HIV transmission in mainland China

48. A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer.

49. Phase Ib/II trial of lenvatinib plus pembrolizumab in urothelial cancer.

50. A phase Ib/II trial of lenvatinib plus pembrolizumab in non-small cell lung cancer.

Catalog

Books, media, physical & digital resources